Introduction
DNA Vaccines Market was valued at USD X.X Billion in 2018 and is projected to reach USD X.X billion by 2025, at a CAGR of X.X % from 2019-2025. The increasing vulnerability of population to infectious diseases and increasing number of antibiotics resistant pathogens have created the need for effective and low-cost vaccination, which would provide long lasting immunity. DNA vaccines have potential advantages over traditional methods, e.g., low risk of infection, easy transportation and stability at room temperature.
Moreover, rapid development in the field of molecular biology, immunology and DNA synthesis would further drive the growth of this market.
Geographical Overview
At a global level, North America region was holding the highest market share in 2018. Whereas, Asia Pacific region is considered as the fastest growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. China and India are offering ample opportunities for the growth of World DNA Vaccines Market with its high population base. Based on geography, the market is segmented into North America, Europe, Asia-Pacific and LAMEA.
Segmental Overview
World DNA Vaccines Market is segmented as per below specifications -
By Product Type:
• Human DNA vaccines
• Animal DNA vaccines
By Consumption:
• Human diseases
• Infectious disease
By Distribution Channel:
• Human health
• Animal health
• Research application
Competitor Analysis
World DNA Vaccines Market has presence of some of the key major players across globe which includes
• Sanofi Aventis
• Pfizer Pharmaceuticals
• Novartis AG
• Merck & Co.
• GlaxoSmithKline Inc.
• Advance Bioscience Laboratories Inc.
• Indian Immunologicals Ltd.
• Xenetic Biosciences Inc.
• QED Biosciences Inc.
These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.
By Geographical Locations:
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
Highlights of the report
What is World DNA Vaccines Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation
Market size projection based on Historical & current market trends
Market share analysis and key strategies adopted by leading Players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations
Chapter 1 Research Objective
1.1 Need of the Research Report
1.2 Client Objectives
1.3 Offered Solutions
Chapter 2 Recommendations
2.1 Executive Summary
2.1.1 Market Overview
2.1.2 Competitive Insights
2.1.3 Segmental Analysis
2.1.4 Geographical Market Details
2.2 Lead Generation
2.3 Consultant
2.4 Return on Investment
Chapter 3 Research Methodology
3.1 Chromatus Database
3.2 Paid Sources
3.3 Primary Data Collection
3.3.1 Email Surveys
3.3.2 Telephonic Interviews
3.3.3 Face to Face Interviews
3.4 Secondary Data Collection
3.4.1 Annual Reports
3.4.2 Government Publications
3.4.3 Trade Data
3.4.4 Association Data
3.4.5 Research Papers/ Blogs/ News Articles
3.5 Expert Advisory Panel
3.6 Data Analytics Model
Chapter 4 World DNA Vaccines Market Overview
4.1 Parent Market Overview
4.2 Patent Analysis
4.3 PESTEL Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Legal
4.4 SWOT Analysis
4.4.1 Strengths
4.4.2 Weakness
4.4.3 Opportunities
4.4.4 Threats
4.5 Regulations
4.6 Value Chain/ Supply Chain Analysis
4.7 Procurement & Vendor Analysis
4.8 Porters Five Analysis
4.8.1 Threat of new entrants
4.8.2 Bargaining power of suppliers
4.8.3 Bargaining power of buyers
4.8.4 Threat of substitutes
4.8.5 Competitive rivalry
Chapter 5 Regional Analysis Global World DNA Vaccines Market Estimation and Forecast, 2017 - 2025 (USD Billion)
5.1 North America Market
5.1.1 U.S.
5.1.1 Canada
5.2 Europe Market
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.2.4 Spain
5.2.5 Italy
5.2.6 Russia & CIS
5.2.7 Rest of Europe
5.3 Asia Pacific Market
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 South Korea
5.3.5 ASEAN
5.3.6 Rest of Asia Pacific
5.4 Rest of the World
5.4.1 Latin America
5.4.1.1 Brazil
5.4.1.2 Argentina
5.4.1.3 Rest of Latin America
5.4.2 Middle East
5.4.3 Africa
Chapter 6 Company Profile
6.1 Sanofi Aventis
6.1.1 Introduction
6.1.2 Financial Overview
6.1.3 Product Portfolio
6.1.4 Recent Developments
6.1.5 SWOT Analysis
6.2 Pfizer Pharmaceuticals
6.3 Novartis AG
6.4 Merck & Co.
6.5 GlaxoSmithKline Inc.
6.6 Advance Bioscience Laboratories Inc.
6.7 Indian Immunologicals Ltd.
6.8 Xenetic Biosciences Inc.
6.9 QED Biosciences Inc.
Chapter 7 Competitor Analysis
7.1 Company Ranking
7.2 Key Innovators
7.3 Market Leader
7.4 Emerging Players
7.5 Strategic Alliances
7.6 Competitive Matrix of 12 Companies
Chapter 8 Global World DNA Vaccines Market by Product Type Estimation and Forecast, 2017 - 2025 (USD Billion)
8.1 Human DNA vaccines
8.2 Animal DNA vaccines
Chapter 9 Global World DNA Vaccines Market by Consumption Type Estimation and Forecast, 2017 - 2025 (USD Billion)
9.1 Human diseases
9.2 Infectious disease
Chapter 10 Global World DNA Vaccines Market by Distribution Channel Estimation and Forecast, 2017 - 2025 (USD Billion)
10.1 Human health
10.2 Animal health
10.3 Research application
Chapter 11 Appendix
11.1 Data Sources
11.2 Abbreviations
11.3 About US
11.4 Disclaimer
11.5 Key Notes
List of Tables
Table 1 Global World DNA Vaccines Market, by Region, 2017 - 2025 (USD Billion)
Table 2 Global World DNA Vaccines Market, by Product Type, 2017 - 2025 (USD Billion)
Table 3 Global World DNA Vaccines Market, by Consumption Type, 2017 - 2025 (USD Billion)
Table 4 Global World DNA Vaccines Market, by Distribution Type, 2017 - 2025 (USD Billion)
Table 5 North America World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 6 North America World DNA Vaccines Market by Product Type 2017 - 2025 (USD Billion)
Table 7 North America World DNA Vaccines Market by Consumption Type 2017 - 2025 (USD Billion)
Table 8 North America World DNA Vaccines Market by Distribution Type 2017 - 2025 (USD Billion)
Table 9 US World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 10 Canada World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 11 Europe World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 12 Europe World DNA Vaccines Market by Product Type 2017 - 2025 (USD Billion)
Table 13 Europe World DNA Vaccines Market by Consumption Type 2017 - 2025 (USD Billion)
Table 14 Europe World DNA Vaccines Market by Distribution Type 2017 - 2025 (USD Billion)
Table 15 UK World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 16 Germany World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 17 France World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 18 Spain World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 19 Italy World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 20 Russia & CIS World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 21 Rest of Europe World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 22 Asia Pacific World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 23 Asia Pacific World DNA Vaccines Market by Product Type 2017 - 2025 (USD Billion)
Table 24 Asia Pacific World DNA Vaccines Market by Consumption Type 2017 - 2025 (USD Billion)
Table 25 Asia Pacific World DNA Vaccines Market by Distribution Type 2017 - 2025 (USD Billion)
Table 26 China World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 27 Japan World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 28 India World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 29 South Korea World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 30 ASEAN World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 31 Rest of Asia Pacific World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 32 Latin America World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 33 Latin America World DNA Vaccines Market by Product Type 2017 - 2025 (USD Billion)
Table 34 Latin America World DNA Vaccines Market by Consumption Type 2017 - 2025 (USD Billion)
Table 35 Latin America World DNA Vaccines Market by Distribution Type 2017 - 2025 (USD Billion)
Table 36 Brazil World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 37 Argentina World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 38 Rest of Latin America World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 39 Middle East World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 40 Middle East World DNA Vaccines Market by Product Type 2017 - 2025 (USD Billion)
Table 41 Middle East World DNA Vaccines Market by Consumption Type 2017 - 2025 (USD Billion)
Table 42 Middle East World DNA Vaccines Market by Distribution Type 2017 - 2025 (USD Billion)
Table 43 Africa World DNA Vaccines Market 2017 - 2025 (USD Billion)
Table 44 Africa World DNA Vaccines Market by Product Type 2017 - 2025 (USD Billion)
Table 45 Africa World DNA Vaccines Market by Consumption Type 2017 - 2025 (USD Billion)
Table 46 Africa World DNA Vaccines Market by Distribution Type 2017 - 2025 (USD Billion)
List of Figures
Fig. 1 Primary Research Method
Fig. 2 Secondary Research Method
Fig. 3 Value chain analysis
Fig. 4 PESTEL Analysis
Fig. 5 SWOT Analysis
Fig. 6 Porters Five forces analysis
Fig. 7 World DNA Vaccines Market: Penetration & growth prospect mapping
Fig. 8 World DNA Vaccines Market: Competitive snapshot
Fig. 9 World DNA Vaccines Market: Segmental snapshot
Fig. 10 Market Overview
Fig. 11 World DNA Vaccines Market: Product Analysis, 2017 - 2025
Fig. 12 World DNA Vaccines Market: Regional Analysis, 2017 - 2025
Fig. 13 World DNA Vaccines Market: Competitive Matrix
Fig. 14 World DNA Vaccines Market: Revenue Mix